Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
about
Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questionsAutoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implicationsClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsNeuronal central nervous system syndromes probably mediated by autoantibodiesAutoimmune encephalitis in psychiatric institutions: current perspectivesAntibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesEmergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis.Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended ImmunotherapiesFocal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitisClinical features of limbic encephalitis with LGI1 antibody.Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilisClinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.A clinical approach to diagnosis of autoimmune encephalitis.A Case of Seronegative Limbic Encephalitis with Multiple Sclerosis: A Possible Overlapping Syndrome.Anti-LGI1 encephalitis is associated with unique HLA subtypes.Immune therapy in autoimmune encephalitis: a systematic review.Diagnostic and therapeutic strategies for management of autoimmune encephalopathies.Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.Suspected new-onset autoimmune temporal lobe epilepsy with amygdala enlargement.Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis.Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.A Genetic Disposition for Autoimmune Encephalitis: Searching for Human Leukocyte Antigen (HLA) Complex Subtypes.New hope for the treatment of epilepsy.Suspected antibody negative autoimmune limbic encephalitis: outcome of immunotherapy.Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation.Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis.Treatment strategies for autoimmune encephalitis.Amygdala enlargement and emotional responses in (autoimmune) temporal lobe epilepsy.Biomarkers of Neurodegeneration in Autoimmune-Mediated EncephalitisHippocampal Functional Dynamics Are Clinically Implicated in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures
P2860
Q26741919-BFCBC446-B5B7-46F0-AFC1-74493A9AC0D6Q26775915-6CB31178-0437-44C9-8071-0DAC5F4D0B55Q26824216-E05FFA87-D545-416A-87CD-67837624BDF3Q28072253-92E0B172-9FA9-42CC-A49F-34029A0C1D5AQ28079666-94D2A37B-303F-4A89-BB1C-35C114CF97A8Q28084055-473ADD27-8A62-44A8-8C60-473FD078635EQ33552867-99E571E7-AB3F-49A5-AA8F-F589122835B6Q33600142-9C5F1C7C-E7BF-49D9-9BD0-D249A16C9579Q33603847-9A731A7A-BBFC-467A-A664-5F808CE7CB41Q33825874-6FD0A189-4EBD-49BE-A851-034E3D429F29Q34490340-ABC26498-A40F-4CB2-9084-BC7522E089B6Q36240987-9FA19FE4-BF97-4216-B11F-DFE5667CE0EFQ37116925-7EB08D1E-6BD2-4528-B921-113D045F5219Q37343730-9966C71B-F800-4B39-B96E-C42017E62B24Q37606419-8678CB02-B7D3-45A2-8308-CD5FB7F70EDCQ38407241-EC4E0A01-DC6C-4D7B-835D-82723859BD1FQ38630867-88F586F7-F40B-4F99-B2D2-71BE0D5B7C72Q38832800-DBCB5798-88D9-4C31-811C-DE04720878A7Q38902329-C7DF24CD-6E40-4331-91F4-A9520DD1F072Q39149611-7B08995A-4354-4EBD-9664-88D644EC0D80Q39247906-A6272A8B-031C-44C4-BCC9-833AB88744D4Q39600619-C7FB1180-A6FE-4D27-B765-DF7AF3716E6EQ40124984-2D6DEB7C-4364-4C68-B5A8-781863F292CEQ41127137-61CFB238-4C69-44DE-B001-C5E377923287Q47148821-2DAF6A96-2050-40C0-A776-7A9B3D776635Q47573219-57D32396-8673-4FE1-9C01-814E3DD9F8FDQ47575846-9A50D444-A784-49AD-A672-E257BFC94C9FQ47705824-39863572-3230-420D-8688-BBD12F2A8FCEQ48095554-25777A64-2EA9-4CF5-881A-A23D3219C34DQ48763396-A9CDBFB1-28D2-4925-943A-AC79677AD48CQ49213573-C4795048-8592-4C0C-BB5A-C33DDE2A2DC5Q55434569-CB350D49-8396-4E32-BC03-9C94978A962CQ57072879-9D926ED5-C026-408C-9E36-8F2F00BF2E65Q57161215-6AEE5C3C-D94F-4208-A7D1-3513E5057B00
P2860
Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@en
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@nl
type
label
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@en
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@nl
prefLabel
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@en
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@nl
P2093
P2860
P1433
P1476
Outcome of limbic encephalitis ...... tion to antigenic specificity.
@en
P2093
A V Vincent
C Helmstaedter
J C Schoene-Bake
K P Wandinger
M P Malter
W Stoecker
P2860
P2888
P304
P356
10.1007/S00415-014-7408-6
P577
2014-06-17T00:00:00Z